ARAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.969200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.503200E-01
Normal-vs-Stage2
5.271200E-01
Normal-vs-Stage3
3.178000E-01
Normal-vs-Stage4
6.052800E-01
Stage1-vs-Stage2
9.764800E-01
Stage1-vs-Stage3
1.673380E-01
Stage1-vs-Stage4
8.568200E-01
Stage2-vs-Stage3
1.562350E-01
Stage2-vs-Stage4
7.903600E-01
Stage3-vs-Stage4
3.756400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.807200E-01
Normal-vs-AfricanAmerican
9.518000E-01
Normal-vs-Asian
2.051800E-01
Caucasian-vs-AfricanAmerican
3.923600E-01
Caucasian-vs-Asian
8.621400E-01
AfricanAmerican-vs-Asian
3.877200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.835200E-01
Normal-vs-Female
5.170200E-01
Male-vs-Female
5.577200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.478000E-01
Normal-vs-Age(41-60Yrs)
3.759400E-01
Normal-vs-Age(61-80Yrs)
4.458200E-01
Normal-vs-Age(81-100Yrs)
4.394600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.267200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.958600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.461600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.341930E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.423600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.225000E-01
Normal-vs-Daily Drinker
4.581400E-01
Normal-vs-Weekly Drinker
3.662400E-01
Normal-vs-Occasional Drinker
3.128200E-01
Normal-vs-Social Drinker
4.706000E-01
Non Drinker-vs-Daily Drinker
4.740200E-01
Non Drinker-vs-Weekly Drinker
7.421900E-02
Non Drinker-vs-Occasional Drinker
5.589400E-01
Non Drinker-vs-Social Drinker
5.880800E-01
Daily Drinker-vs-Weekly Drinker
3.084000E-01
Daily Drinker-vs-Occasional Drinker
2.771000E-01
Daily Drinker-vs-Social Drinker
9.159800E-01
Weekly Drinker-vs-Occasional Drinker
5.699900E-02
Weekly Drinker-vs-Social Drinker
2.686200E-01
Occasional Drinker-vs-Social Drinker
3.629200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.519400E-01
Normal-vs-Grade 2
1.113820E-02
Normal-vs-Grade 3
5.940700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.363600E-01
Grade 1-vs-Grade 3
1.477650E-01
Grade 1-vs-Grade 4
2.519400E-01
Grade 2-vs-Grade 3
6.745900E-02
Grade 2-vs-Grade 4
1.113820E-02
Grade 3-vs-Grade 4
5.940700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.438000E-01
Normal-vs-NonDiabetic
4.683600E-01
Diabetic-vs-NonDiabetic
6.430200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.725600E-01
Normal-vs-NoPancreatitis
4.555200E-01
Pancreatitis-vs-NoPancreatitis
2.430800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.751000E-01
Normal-vs-N1
5.172400E-01
N0-vs-N1
4.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.903400E-01
Normal-vs-TP53-NonMutant
4.885200E-01
TP53-Mutant-vs-TP53-NonMutant
2.623800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
